DaVita (DVA +2.3%) spiked — and then gave up those gains and then some — after reports emerging this hour about the FTC approving UnitedHealth Group’s (UNH +2%) $4.34B acquisition of DaVita Medical Group.
Shares in DaVita rose as high as 7% a short while ago before quickly falling back.
The deal covers a network of nearly 300 clinics that treat more than 1.7M patients a year.
That deal was supposed to close in 2018 but missed a few deadlines.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.